Antares Pharma, Inc. FDA Record
- Latest inspection NAI · Jan 16, 2025
- No warning letters matched by name
Antares Pharma, Inc. has 0 FDA recalls, 7 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Antares Pharma, Inc." is on file.
- Latest inspection
- Jan 16, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 7 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Antares Pharma, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Antares Pharma, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Antares Pharma, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jan 16, 2025 | Minnetonka, MN | Drugs | No Action Indicated (NAI) | 2182861 |
| Dec 4, 2018 | Minnetonka, MN | Devices | Voluntary Action Indicated (VAI) | 2182861 |
| Feb 27, 2017 | Ewing, NJ | Drugs | No Action Indicated (NAI) | 3008877713 |
| Jan 21, 2016 | Minnetonka, MN | Devices | No Action Indicated (NAI) | 2182861 |
| Sep 6, 2012 | Minnetonka, MN | Devices | No Action Indicated (NAI) | 2182861 |
| Aug 20, 2012 | Ewing, NJ | Devices | No Action Indicated (NAI) | 3008877713 |
| Jul 14, 2009 | Minnetonka, MN | Devices | No Action Indicated (NAI) | 2182861 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 2182861 | Minnetonka, MN | 5 | Jan 16, 2025 |
| FEI 3008877713 | Ewing, NJ | 2 | Feb 27, 2017 |
Antares Pharma, Inc. and the FDA: common questions
Has Antares Pharma, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Antares Pharma, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Antares Pharma, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Antares Pharma, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Antares Pharma, Inc.?
The most recent FDA inspection on file ended Jan 16, 2025 at Minnetonka, MN and was classified NAI. FDA has 7 inspections of Antares Pharma, Inc. on file.
Need more than this page shows? Ask about Antares Pharma, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.